HARROW HEALTH, INC. Human Resources Contracts & Agreements
35 Contracts & Agreements
- Bonus & Incentive Agreements (11 contracts)
- Consulting Agreements (15)
- Employment Agreements (9)
- Consulting Agreement dated July 1, 2020 between Visionology, Inc. and Andrew R. Boll (Filed With SEC on March 8, 2021)
- Consulting Agreement dated July 1, 2020 between Visionology, Inc. and Mark L. Baum (Filed With SEC on March 8, 2021)
- Consulting Agreement dated February 13, 2020 between Stowe Pharmaceuticals, Inc. and John P. Saharek (Filed With SEC on March 13, 2020)
- Consulting Agreement dated February 13, 2020 between Stowe Pharmaceuticals, Inc. and Andrew R. Boll (Filed With SEC on March 13, 2020)
- Consulting Agreement dated February 13, 2020 between Stowe Pharmaceuticals, Inc. and Mark L. Baum (Filed With SEC on March 13, 2020)
- Consulting Agreement dated June 3, 2019 between Mayfield Pharmaceuticals, Inc. and John P. Saharek (Filed With SEC on August 14, 2019)
- Consulting Agreement dated June 3, 2019 between Mayfield Pharmaceuticals, Inc. and Mark L. Baum (Filed With SEC on August 14, 2019)
- Consulting Agreement dated June 3, 2019 between Mayfield Pharmaceuticals, Inc. and Andrew R. Boll (Filed With SEC on August 14, 2019)
- Consulting Agreement dated May 1, 2018 between Melt Pharmaceuticals, Inc. and John P. Saharek (Filed With SEC on November 13, 2018)
- Consulting Agreement dated May 1, 2018 between Melt Pharmaceuticals, Inc. and Andrew R. Boll (Filed With SEC on November 13, 2018)
- Consulting Agreement dated May 1, 2018 between Melt Pharmaceuticals, Inc. and Mark L. Baum (Filed With SEC on November 13, 2018)
- Consulting Agreement dated March 1, 2018 between Surface Pharmaceuticals, Inc. and Richard L. Lindstrom, M.D (Filed With SEC on August 6, 2018)
- Consulting Agreement dated October 27, 2017 between Surface Pharmaceuticals, Inc. and John P. Saharek (Filed With SEC on March 8, 2018)
- Consulting Agreement dated October 27, 2017 between Surface Pharmaceuticals, Inc. and Andrew R. Boll (Filed With SEC on March 8, 2018)
- Consulting Agreement dated October 27, 2017 between Surface Pharmaceuticals, Inc. and Mark L. Baum (Filed With SEC on March 8, 2018)
- IMPRIMISPHARMACEUTICALS, INC. AMENDED AND RESTATED 2007 INCENTIVE STOCK AND AWARDS PLAN PERFORMANCESTOCK UNITS AGREEMENT (Filed With SEC on April 26, 2016)
- IMPRIMISPHARMACEUTICALS, INC. AMENDED AND RESTATED 2007 INCENTIVE STOCK AND AWARDS PLAN PERFORMANCESTOCK UNITS AGREEMENT (Filed With SEC on April 26, 2016)
- IMPRIMIS PHARMACEUTICALS, INC. AMENDED AND RESTATED 2007 INCENTIVESTOCK AND AWARDS PLAN PERFORMANCE STOCK UNITS AGREEMENT (Filed With SEC on February 2, 2015)
- IMPRIMISPHARMACEUTICALS, INC. AMENDEDAND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on February 2, 2015)
- AmendmentNo. 1 to the Imprimis Pharmaceuticals, Inc. Amendedand Restated 2007 Incentive Stock and Awards Plan (Filed With SEC on November 6, 2013)
- IMPRIMIS PHARMACEUTICALS, INC. PERFORMANCE STOCK UNITS AGREEMENT (Filed With SEC on August 14, 2013)
- IMPRIMIS PHARMACEUTICALS, INC. AMENDED AND RESTATED 2007 INCENTIVE STOCK AND AWARDS PLAN NOTICE OF RESTRICTED STOCK UNIT AWARD Grantees Name and Address: (Filed With SEC on May 8, 2013)
- IMPRIMIS PHARMACEUTICALS, INC. AMENDED AND RESTATED 2007 INCENTIVE STOCK AND AWARDS PLAN (as amended and restated on May 2, 2013) (Filed With SEC on May 8, 2013)
- AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on May 8, 2013)
- IMPRIMIS PHARMACEUTICALS, INC. AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on July 25, 2012)
- AMENDMENT NO. 3 TO THE IMPRIMIS PHARMACEUTICALS, INC. 2007 INCENTIVE STOCK AND AWARDS PLAN (Filed With SEC on July 25, 2012)
- Employment Agreement, dated as of February 15, 2012, by and between Imprimis Pharmaceuticals, Inc. and Joachim Schupp, M.D (Filed With SEC on May 10, 2012)
- Employment Agreement, dated as of February 1, 2012, by and between Imprimis Pharmaceuticals, Inc. and Andrew R. Boll (Filed With SEC on May 10, 2012)
- Employment Agreement, dated as of January 25, 2012, by and between Imprimis Pharmaceuticals, Inc. and Dr. Balbir Brar, D.V.M., Ph.D (Filed With SEC on May 10, 2012)
- Exhibit 10.5 IMPRIMIS PHARMACEUTICALS, INC. EMPLOYMENT AGREEMENT (Filed With SEC on April 27, 2012)
- TRANSDEL PHARMACEUTICALS, INC. 2007 INCENTIVE STOCK AND AWARD PLAN FORM OF NONQUALIFIED STOCK OPTION AGREEMENT (Filed With SEC on September 21, 2007)
- TRANSDEL PHARMACEUTICALS, INC. 2007 INCENTIVE STOCK AND AWARDS PLAN FORM OF INCENTIVE STOCK OPTION AGREEMENT (Filed With SEC on September 21, 2007)
- TRANSDEL PHARMACEUTICALS, INC. 2007 INCENTIVE STOCK AND AWARDS PLAN (Filed With SEC on September 21, 2007)
- EMPLOYMENT AGREEMENT (Filed With SEC on September 21, 2007)
- ASSIGNMENT OF EMPLOYMENT AGREEMENT (Filed With SEC on September 21, 2007)
